오령산의 고혈압 치료 효과에 대한 체계적 고찰 : 임상 논문을 중심으로
A Systematic Review on Antihypertensive Effects of Oryeong-san
2
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
Objectives : The purpose of this study was to review the clinical studies on antihypertensive effects of Oryeong-san. Methods : We searched papers using KTKP, Oasis, CNKI, PubMed, Embase, Science Direct, CINAHL, J STAGE and CiNii, and the key words “Oryeong-san (韓)”, “Wuling-san (中)”, “Gorei-san (日)”, and “Hypertension” were used. Search range included randomized controlled trials (RCTs), clinical reports, reviews and animal experiments. Papers not matched with inclusion criteria were excluded. Results : A total 479 studies were found, with 457 excluded during title and abstract screening. After scanning 22 papers, a final 3 RCTs and 6 case reports were selected and analyzed. In the 3 RCTs, the number of patients varied between 65 and 156. Patients with hypertension were randomized into groups for treatment group and control group. They were all treated with antihypertensive drugs (Vamlodipine Besylate, Benazepril, Perindopril); the treatment group was also given modified Oryeong-san. After treatment, results were that blood pressure was significantly decreased in the treatment group, compared to the control. The other 6 case reports reported that modified Oryeong-san alone or the combination of Oryeong-san plus antihypertensive drugs had beneficial effects on blood pressure. Conclusions : Oryeong-san appears to be effective in improving blood pressure and hypertension-related symptoms. The results of this study could be applied to clinical treatment of hypertension. Further large-scale clinical researches should be conducted.
Abstract
Objectives : The purpose of this study was to review the clinical studies on antihypertensive effects of Oryeong-san. Methods : We searched papers using KTKP, Oasis, CNKI, PubMed, Embase, Science Direct, CINAHL, J STAGE and CiNii, and the key words “Oryeong-san (韓)”, “Wuling-san (中)”, “Gorei-san (日)”, and “Hypertension” were used. Search range included randomized controlled trials (RCTs), clinical reports, reviews and animal experiments. Papers not matched with inclusion criteria were excluded. Results : A total 479 studies were found, with 457 excluded during title and abstract screening. After scanning 22 papers, a final 3 RCTs and 6 case reports were selected and analyzed. In the 3 RCTs, the number of patients varied between 65 and 156. Patients with hypertension were randomized into groups for treatment group and control group. They were all treated with antihypertensive drugs (Vamlodipine Besylate, Benazepril, Perindopril); the treatment group was also given modified Oryeong-san. After treatment, results were that blood pressure was significantly decreased in the treatment group, compared to the control. The other 6 case reports reported that modified Oryeong-san alone or the combination of Oryeong-san plus antihypertensive drugs had beneficial effects on blood pressure. Conclusions : Oryeong-san appears to be effective in improving blood pressure and hypertension-related symptoms. The results of this study could be applied to clinical treatment of hypertension. Further large-scale clinical researches should be conducted.
참고문헌 (28)
- 대한고혈압학회, "고혈압", pp.7~ (2009), 대한의학서적
- Chobanian AV, "The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report", JAMA, pp.2560~2572 (2003)
- 전국한의과대학심계내과학교실, "한방순환신경내과학", pp.171~ (2010), 군자출판사
- 蔡光先, "中西醫結合內科學", pp.181~191 (2005), 中國中醫學出版社
- 정진원, "고혈압의 최신진료지침과 약제선택", 대한내과학회지, 80(3), pp.280~285 (2011), 대한내과학회
- 한의과대학 방제학교수, "방제학", pp.504~506 (2003), 영림사
- 윤용갑, "동의방제와 처방해설", pp.429~433 (2007), 의성당
- 彭紹傑, "施慧達聯合丹芪五苓散治療原發性高血壓80例療效觀察", 雲南中醫中藥雜志, 32(9), pp.23~24 (2011)
- 全毅紅, "加味五苓散合六味地黃湯對早期高血壓腎損害的作用研究", 首都醫藥, 下, pp.44~46 (2011)
- 範玉網, "五苓散治療代謝綜合征的理論和臨床研究", 박사, pp.2012
- 星野 綾美, "アンギオテンシンIIレセプターブロッカーでコントロール不十分な高血圧症に五苓散の併用が奏効した一例", 北関東医学, 59(2), pp.176~ (2009)
- 胡智芬, "五苓散加味聯合苯磺酸氨氯地平治療慢性腎炎高血壓下肢水腫醫案一則", 實用中醫內科雜志, 26(8), pp.65~66 (2012)
- 朱沛冉, "五苓散治愈腎性高血壓", 四川中醫, 22 (1987)
- 矢數道明, "用八物降下湯合五苓散治療高血壓和浮腫", 醫學文選, pp.62~63 (1987)
- 俞大毛, "五苓散對血壓、大便的雙相調節作用", 中國實驗方劑學雜志, 3(1), pp.44~45 (1997)
- Okabe T, "Differential diagnosis of arterial hypertension by systems review and treatment with medicinal herbs: A preliminary report", Int Med J, 14(2), pp.113~116 (2007)
- 2011 국민건강통계 국민건강영양조사 제 5기 2차년도, "보건복지부", 질병관리본부, 415~420 (2012)
- 이원로, "JNC-7: 새로운 고혈압 관리지침의 개요", 심장과 혈관, pp.7~ (2003)
- 고혈압 한의 임상진료지침, In 한의약 만성질환 관리제도 도입 방안 연구, "장인수", 보건복지부, 195~271 (2012)
- 박경호, "청열도담탕이 고혈압에 미치는 영향", 동의생리병리학회지, 21(3), pp.626~633 (2007), 대한동의병리학회
- 장인수, "뇌혈관질환에 대한 五苓散 치료의 일본 유용성 : 2011년 제20회 일본뇌신경외과한방의학회 학술대회 발표논문을 중심으로", 대한중풍학회지, 11(1), pp.1~7 (2011)
- 미야가미 미쯔스케(松上 光祐), "뇌신경질환의 한방치료", pp.20~21 (2011), 군자출판사
- 김창석, "고혈압의 한약 치료에 대한 연구동향 분석", 대한예방한의학회지, 15(3), pp.17~38 (2011), 대한예방한의학회
- Jamerson K, "Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high- risk patients", N Engl J Med, 359(23), pp.2417~2428 (2008)
- National Clinical Guideline Centre (UK), "Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34", Royal College of Physicians (UK), ~ (2011)
- Task Force for the management of arterial hypertension of the European Society of Hypertension, "2013 ESH", ESC Guidelines for the Management of Arterial Hypertension, 2013, pp.34(28), 2159~2219
- 채성철, "이뇨제가 최우선인가", 심장과혈관, 5(3), pp.11~15 (2003)
- "고혈압 치료에 이뇨제가 꼭 필요한가" (2003)[URL]